Celgene Corporation To Announce Third Quarter Results On November 3, 2005

SUMMIT, N.J., Oct. 28 /PRNewswire-FirstCall/ -- Celgene Corporation senior management team plans to report its third quarter financial and operational results on Thursday, November 3, 2005 at 8:00 am EST, before the open of the financial markets. The webcast will be available in the investor relations section of the Company's website at http://www.celgene.com.

Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of novel therapies for the treatment of cancer and immuno-inflammatory diseases through gene and protein regulation. For more information, please visit the Company's website at http://www.celgene.com.

This release contains certain forward-looking statements which involve known and unknown risks, delays, uncertainties and other factors not under the Company's control, which may cause actual results, performance or achievements of the Company to be materially different from the results, performance or other expectations implied by these forward-looking statements. These factors include results of current or pending research and development activities, actions by the FDA and other regulatory authorities, and those factors detailed in the Company's filings with the Securities and Exchange Commission such as 10K, 10Q and 8K reports.

CONTACT: Robert J. Hugin, Senior VP and CFO, +1-908-673-9000, or Brian P.Gill, Director IR-PR, both of +1-908-673-9000, both of Celgene Corporation

Web site: http://www.celgene.com//